AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2004
Dec 30, 2004
30786_dirs_2004-12-30_6ed07769-6d92-46bb-812d-8b831f273dd2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO)
CIK: 0000012208
Period of Report: 2004-12-29
Reporting Person: CRUTCHFIELD BRADFORD (Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2004-12-29 | Bio-Rad A Common Stock | M | 1800 | $11.94 | Acquired | 2924 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2004-12-29 | Incentive Stock Option (right to buy) | $11.94 | M | 1800 | Disposed | 2010-02-02 | Bio-Rad A Common Stock (1800) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $10.75 | 2010-09-19 | Bio-Rad A Common Stock (10200) | 10200 | Direct |
| Incentive Stock Option (right to buy) | $28.61 | 2012-02-06 | Bio-Rad A Common Stock (4000) | 4000 | Direct |
| Incentive Stock Option (right to buy) | $35.5 | 2013-02-05 | Bio-Rad A Common Stock (8870) | 8870 | Direct |
| Incentive Stock Option (right to buy) | $53.75 | 2014-02-04 | Bio-Rad A Common Stock (2738) | 2738 | Direct |
| Non-Qualified Stock Option (right to buy) | $35.5 | 2013-02-05 | Bio-Rad A Common Stock (1130) | 1130 | Direct |
| Non-Qualified Stock Option (right to buy) | $53.75 | 2014-02-04 | Bio-Rad A Common Stock (5262) | 5262 | Direct |
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13